Market Cap 26.26M
Revenue (ttm) 1.27M
Net Income (ttm) -69.69M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -5,487.40%
Debt to Equity Ratio 0.00
Volume 519,800
Avg Vol 1,007,208
Day's Range N/A - N/A
Shares Out 41.03M
Stochastic %K 69%
Beta 0.31
Analysts Hold
Price Target $0.97

Company Profile

Vistagen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for neuropsychiatric and neurological disorders. The company's product pipeline includes Fasedienol, an investigational pherine nasal spray that is in Phase III clinical trial for the treatment of anxiety in adults with social anxiety disorder; and Itruvone, an odorless synthetic investigational neuroactive pherine nasal spray, which is in Phase II clinical trial...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 577 3600
Address:
343 Allerton Avenue, South San Francisco, United States
Robertigno
Robertigno Jun. 25 at 9:18 AM
$VTGN se i dati sono positivi escono oggi. Se sono negativi li faranno uscire domani. Il venerdi e' dedicato da wall street alle notizie negative. Per cui comportatevi di conseguenza. Non li faranno uscire l ultimo giorno utile.
0 · Reply
Diaper_Man
Diaper_Man Jun. 25 at 8:50 AM
0 · Reply
ThaDankles
ThaDankles Jun. 25 at 2:27 AM
$VTGN I’m pretty sure I will Hold through an offering. I know it will dip but honestly I think the hold will be worth it because of good results should lead to NDA or buyout or both by March and a 20-30$ pps which will be great timing for capital gains!
1 · Reply
Edgebell
Edgebell Jun. 24 at 10:15 PM
$VTGN if data is positive , there is no better day then tomorrow am to release. I could see Pr happening tomorrow and if solid results, it wood set company up for a raise Friday ah. Biotechs always like to raise into a weekend.
1 · Reply
Diaper_Man
Diaper_Man Jun. 24 at 9:10 PM
1 · Reply
seppi
seppi Jun. 24 at 8:58 PM
$VTGN big fall ah! Pump and dump or bad news?
3 · Reply
Hisoni
Hisoni Jun. 24 at 8:49 PM
$VTGN In the stock market, it is common for stock prices to surge by nearly 20% before official major announcements (such as M&A, clinical trial results, the unveiling of innovative new products, or earnings surprises). Investors may wonder, "Why is the price rising before the announcement?" The main causes can be summarized into four key points. 1. Information Asymmetry and Non-public Information Leakage This is the most common yet bitter reality. No matter how strictly security is maintained, numerous people (internal employees, law firms, accounting firms, investment banking consultants, etc.) become involved before a major corporate announcement. • During this process, rumors circulate in the market, or forces that have obtained non-public information in advance (insiders or institutional investors) engage in **preemptive buying**, causing trading volume to explode and the stock price to skyrocket. rmarket.
1 · Reply
LDCap
LDCap Jun. 24 at 8:44 PM
$VTGN all I'm reading is a bunch of scared retail holders predicting prices between $1-5, This means a market capital of between 40m to 200 m for a revolutionary drug with a TAM of 2-4 billion. Sickening!. Yes, it's a complete coin flip but if its unequivocally successful you're looking at upwards of $20 within weeks and a BO candidate with a target price of $35 minimum. Not investment advice but for heavens sake, use some logic.
1 · Reply
Alexandro8787
Alexandro8787 Jun. 24 at 8:43 PM
$VTGN In my opinion, it’s best to exit on Friday before the close. Friday evening announcements are not good at all.
1 · Reply
jmuu001
jmuu001 Jun. 24 at 8:33 PM
$VTGN Somebody came home happy and decided to pump this into the close. Tomorrow am it shall be then...
0 · Reply
Latest News on VTGN
Vistagen Therapeutics Earnings release: Q4 2026

Jun 15, 2026, 4:00 PM EDT - 9 days ago

Vistagen Therapeutics Earnings release: Q4 2026


Vistagen Therapeutics Annual report: Q4 2026

Jun 15, 2026, 4:00 PM EDT - 9 days ago

Vistagen Therapeutics Annual report: Q4 2026


Vistagen appoints Angelov as Chief Medical Officer

2026-05-19T12:37:06.000Z - 5 weeks ago

Vistagen appoints Angelov as Chief Medical Officer


Vistagen Therapeutics Transcript: Stifel 2026 Virtual CNS Forum

Mar 17, 2026, 9:00 AM EDT - 3 months ago

Vistagen Therapeutics Transcript: Stifel 2026 Virtual CNS Forum


Vistagen to Participate in Upcoming Investor Conferences

Mar 3, 2026, 8:30 AM EST - 4 months ago

Vistagen to Participate in Upcoming Investor Conferences


Vistagen Therapeutics Earnings Call Transcript: Q3 2026

Feb 12, 2026, 5:00 PM EST - 4 months ago

Vistagen Therapeutics Earnings Call Transcript: Q3 2026


Vistagen Therapeutics Quarterly report: Q3 2026

Feb 12, 2026, 5:00 PM EST - 4 months ago

Vistagen Therapeutics Quarterly report: Q3 2026


Vistagen Therapeutics Earnings release: Q3 2026

Feb 12, 2026, 5:00 PM EST - 4 months ago

Vistagen Therapeutics Earnings release: Q3 2026


Vistagen downgraded to Hold from Buy at Jefferies

2025-12-17T19:25:24.000Z - 6 months ago

Vistagen downgraded to Hold from Buy at Jefferies


Vistagen downgraded to Hold from Buy at Maxim

2025-12-17T17:20:14.000Z - 6 months ago

Vistagen downgraded to Hold from Buy at Maxim


Vistagen downgraded to Hold from Buy at Stifel

2025-12-17T15:45:17.000Z - 6 months ago

Vistagen downgraded to Hold from Buy at Stifel


Vistagen downgraded to Neutral from Buy at Lucid Capital

2025-12-17T14:40:46.000Z - 6 months ago

Vistagen downgraded to Neutral from Buy at Lucid Capital


Vistagen SAD study did not achieve primary endpoint

2025-12-17T14:05:58.000Z - 6 months ago

Vistagen SAD study did not achieve primary endpoint


VistaGen Therapeutics trading resumes

2025-12-17T13:55:10.000Z - 6 months ago

VistaGen Therapeutics trading resumes


VistaGen Therapeutics trading halted, news pending

2025-12-17T13:25:17.000Z - 6 months ago

VistaGen Therapeutics trading halted, news pending


Vistagen names Nick Tressler CFO

2025-12-01T14:00:20.000Z - 7 months ago

Vistagen names Nick Tressler CFO


Vistagen Appoints Nick Tressler as Chief Financial Officer

Dec 1, 2025, 8:30 AM EST - 7 months ago

Vistagen Appoints Nick Tressler as Chief Financial Officer


Vistagen Therapeutics Earnings Call Transcript: Q2 2026

Nov 13, 2025, 5:00 PM EST - 7 months ago

Vistagen Therapeutics Earnings Call Transcript: Q2 2026


Vistagen Therapeutics Quarterly report: Q2 2026

Nov 13, 2025, 5:00 PM EST - 7 months ago

Vistagen Therapeutics Quarterly report: Q2 2026


Vistagen Therapeutics Earnings release: Q2 2026

Nov 13, 2025, 5:00 PM EST - 7 months ago

Vistagen Therapeutics Earnings release: Q2 2026


Vistagen to Participate in Stifel Healthcare Conference 2025

Nov 5, 2025, 8:30 AM EST - 8 months ago

Vistagen to Participate in Stifel Healthcare Conference 2025


Vistagen Appoints Paul Edick to its Board of Directors

Oct 29, 2025, 8:30 AM EDT - 8 months ago

Vistagen Appoints Paul Edick to its Board of Directors


Vistagen to Present at The Menopause Society 2025 Annual Meeting

Oct 16, 2025, 8:30 AM EDT - 8 months ago

Vistagen to Present at The Menopause Society 2025 Annual Meeting


Vistagen Therapeutics Transcript: AGM 2025

Sep 9, 2025, 12:00 PM EDT - 10 months ago

Vistagen Therapeutics Transcript: AGM 2025


Vistagen Therapeutics Earnings Call Transcript: Q1 2026

Aug 7, 2025, 5:00 PM EDT - 11 months ago

Vistagen Therapeutics Earnings Call Transcript: Q1 2026


Vistagen Therapeutics Quarterly report: Q1 2026

Aug 7, 2025, 5:00 PM EDT - 11 months ago

Vistagen Therapeutics Quarterly report: Q1 2026


Vistagen Therapeutics Earnings release: Q1 2026

Aug 7, 2025, 5:00 PM EDT - 11 months ago

Vistagen Therapeutics Earnings release: Q1 2026


Vistagen Therapeutics Proxy statement: Proxy Filing

Jul 28, 2025, 8:00 AM EDT - 11 months ago

Vistagen Therapeutics Proxy statement: Proxy Filing


Vistagen Therapeutics Proxy statement: Proxy Filing

Jul 28, 2025, 8:00 AM EDT - 11 months ago

Vistagen Therapeutics Proxy statement: Proxy Filing


Vistagen to Present at the BTIG Virtual Biotechnology Conference

Jul 24, 2025, 8:30 AM EDT - 11 months ago

Vistagen to Present at the BTIG Virtual Biotechnology Conference


Vistagen Therapeutics Earnings Call Transcript: Q4 2025

Jun 17, 2025, 5:00 PM EDT - 1 year ago

Vistagen Therapeutics Earnings Call Transcript: Q4 2025


Vistagen Therapeutics Earnings release: Q4 2025

Jun 17, 2025, 5:00 PM EDT - 1 year ago

Vistagen Therapeutics Earnings release: Q4 2025


Vistagen Therapeutics Annual report: Q4 2025

Jun 17, 2025, 5:00 PM EDT - 1 year ago

Vistagen Therapeutics Annual report: Q4 2025


Vistagen Therapeutics Transcript: Stifel 2025 Virtual CNS Forum

Mar 18, 2025, 12:00 PM EDT - 1 year ago

Vistagen Therapeutics Transcript: Stifel 2025 Virtual CNS Forum


Vistagen to Participate in Stifel 2025 Virtual CNS Forum

Mar 4, 2025, 8:30 AM EST - 1 year ago

Vistagen to Participate in Stifel 2025 Virtual CNS Forum


Robertigno
Robertigno Jun. 25 at 9:18 AM
$VTGN se i dati sono positivi escono oggi. Se sono negativi li faranno uscire domani. Il venerdi e' dedicato da wall street alle notizie negative. Per cui comportatevi di conseguenza. Non li faranno uscire l ultimo giorno utile.
0 · Reply
Diaper_Man
Diaper_Man Jun. 25 at 8:50 AM
0 · Reply
ThaDankles
ThaDankles Jun. 25 at 2:27 AM
$VTGN I’m pretty sure I will Hold through an offering. I know it will dip but honestly I think the hold will be worth it because of good results should lead to NDA or buyout or both by March and a 20-30$ pps which will be great timing for capital gains!
1 · Reply
Edgebell
Edgebell Jun. 24 at 10:15 PM
$VTGN if data is positive , there is no better day then tomorrow am to release. I could see Pr happening tomorrow and if solid results, it wood set company up for a raise Friday ah. Biotechs always like to raise into a weekend.
1 · Reply
Diaper_Man
Diaper_Man Jun. 24 at 9:10 PM
1 · Reply
seppi
seppi Jun. 24 at 8:58 PM
$VTGN big fall ah! Pump and dump or bad news?
3 · Reply
Hisoni
Hisoni Jun. 24 at 8:49 PM
$VTGN In the stock market, it is common for stock prices to surge by nearly 20% before official major announcements (such as M&A, clinical trial results, the unveiling of innovative new products, or earnings surprises). Investors may wonder, "Why is the price rising before the announcement?" The main causes can be summarized into four key points. 1. Information Asymmetry and Non-public Information Leakage This is the most common yet bitter reality. No matter how strictly security is maintained, numerous people (internal employees, law firms, accounting firms, investment banking consultants, etc.) become involved before a major corporate announcement. • During this process, rumors circulate in the market, or forces that have obtained non-public information in advance (insiders or institutional investors) engage in **preemptive buying**, causing trading volume to explode and the stock price to skyrocket. rmarket.
1 · Reply
LDCap
LDCap Jun. 24 at 8:44 PM
$VTGN all I'm reading is a bunch of scared retail holders predicting prices between $1-5, This means a market capital of between 40m to 200 m for a revolutionary drug with a TAM of 2-4 billion. Sickening!. Yes, it's a complete coin flip but if its unequivocally successful you're looking at upwards of $20 within weeks and a BO candidate with a target price of $35 minimum. Not investment advice but for heavens sake, use some logic.
1 · Reply
Alexandro8787
Alexandro8787 Jun. 24 at 8:43 PM
$VTGN In my opinion, it’s best to exit on Friday before the close. Friday evening announcements are not good at all.
1 · Reply
jmuu001
jmuu001 Jun. 24 at 8:33 PM
$VTGN Somebody came home happy and decided to pump this into the close. Tomorrow am it shall be then...
0 · Reply
LP1922
LP1922 Jun. 24 at 8:20 PM
$VTGN What kind of person bets against a company that develops medicines? You’re absolute scum!
0 · Reply
Robertigno
Robertigno Jun. 24 at 8:01 PM
$VTGN ci siamo.....
2 · Reply
Edgebell
Edgebell Jun. 24 at 7:59 PM
$VTGN Here comes the call buying!!
1 · Reply
Richricx
Richricx Jun. 24 at 7:57 PM
$VTGN I believe the results are known and will be released AH today I think it will show markable improvements 
1 · Reply
Richricx
Richricx Jun. 24 at 7:56 PM
$VTGN If they release Friday AH then the results did not show markable improvement . You will be able to buy this thing for $.20 The conference call on Monday will be nothing IF in fact, that scenario pans out 
0 · Reply
Johnnytwofour2
Johnnytwofour2 Jun. 24 at 7:46 PM
$VTGN The results are what they are. If they successfully narrowed a subset down that shows favorable outcomes and is statistically significant, this potentially becomes a $1 stock again. If its another miss, all the spin in the world won't save this. Its a coin flip bet. Bears could be right, bulls could be right. It all remains to be seen. The classic move with these is to announce Friday in the AH that the data will be released the following Monday and to schedule a call to go over the details. 9/10 its the way this type of data release is handled.
0 · Reply
Robertigno
Robertigno Jun. 24 at 6:59 PM
$VTGN 5 dollari
0 · Reply
Diaper_Man
Diaper_Man Jun. 24 at 6:49 PM
1 · Reply
Thebullsafool
Thebullsafool Jun. 24 at 6:21 PM
0 · Reply
Diaper_Man
Diaper_Man Jun. 24 at 5:37 PM
$VTGN Emergency Broadcast …Alert ..Alert..Alert
3 · Reply
Gemini7777
Gemini7777 Jun. 24 at 5:35 PM
$VTGN buy
0 · Reply
modernaproblema
modernaproblema Jun. 24 at 5:27 PM
$VTGN don’t worry, nobody knows anything…
0 · Reply